Found 11 matching trials
The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study
N/AThe primary hypothesis is that titration of ACE inhibitor and Angiotensin R...
Location
University of Alabama at Birmingham
Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
PHASE2The aim of this cross-over trial is to assess aliskiren, a direct renin inh...
Location
Sahlgrenska Hospital
Treatment of Patients With Diabetic Kidney Disease
NADue to irrespective of the limitations associated with estimated glomerular...
Location
Multiple Locations
An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan
N/AThis is an observational study in which data already collected from people ...
The Effect of Aliskiren and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients
PHASE4This is a prospective, randomized, placebo controlled, multi-center clinica...
Location
Chulalongkorn University
Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
NAContrast induced nephropathy (CIN) is a well-known possible complication of...
Location
An-Najah National University Hospital
Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
PHASE4The purpose of the study was to determine the effect of LCZ696 vs. enalapri...
Location
Novartis Investigative Site
The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients
PHASE4A prospective, randomized, open-label, Single-center clinical trial to dete...
Location
Chulalongkorn university
Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics
PHASE4It is controversial whether or not patients whose Renin Angiotensin System ...
Location
London Health Sciences Centre - Victoria Campus
Rituximab in Recurrent IgA Nephropathy
PHASE4Currently, the treatment options of recurrent IgA nephropathy (IgAN) are co...
Location
Chulalongkorn University